Join the Oncology Voice Network. Join for Free
Insight about INSIGHTS, and how they can help your MSL career!
MSL insights medical affairs career digital tools in field medical hybrid MSL interactions evolving MSL role

Insight about INSIGHTS, and how they can help your MSL career!


Share This Article


Summary

In this episode, Joe Liberman shares his journey from MSL to Associate Director, offering valuable advice on transitioning roles within medical affairs. He delves into the role of an Insights Lead, emphasizing the significance of MSL insights and how to effectively gather and report them. Joe discusses the impact of insights on MSL performance evaluation and provides year-end performance advice. The conversation shifts to the influence of digital tools on field medical, adaptation strategies, and the future of MSL interactions in a hybrid model. Joe concludes with reflections on the evolving role of MSLs with emerging technologies, expressing gratitude and appreciation.

Joe Liberman, Associate  Director, Medical Affairs at UniQure discusses MSL insights and how they can help your career.

Joe shares…

👉 What makes a good MSL Insight and why they are so important

👉 How to effectively go about gathering Insights

👉 Best practices for reporting insights

👉 Advice on how to find success and improve performance

👉 What MSL can expect for 2022

Click for Source
MSL insights, medical affairs career, digital tools in field medical, hybrid MSL interactions, evolving MSL role

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
How to Leverage YOUR Unique Skills for Career Advantage
Partner Avatar MSL Talk: Tom Caravela, Hahn-Ey Lee

How to Leverage YOUR Unique Skills for Career Advantage

Podcast
A Trip Around the MSL Insights Cycle
Partner Avatar MSL Talk: Tom Caravela

A Trip Around the MSL Insights Cycle

Article
Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?
OVN Avatar Omer Ben‐Aharon, Racheli Magnezi, Moshe Leshno, and Daniel A. Goldstein

Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?

Press Release
Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes
OVN Avatar OVN Staff

Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes

Press Release
Introducing OncologyVoiceNetwork.com
OVN Avatar OVN Staff

Introducing OncologyVoiceNetwork.com

Article
Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020
OVN Avatar A. Haslam, M.S. Kim, V. Prasad

Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020

Explore OVN